Significant increase in volume has been observed in GlaxoSmithKline Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has observed a significant increase in trading volume in GlaxoSmithKline Pharmaceuticals Limited shares. As a standard regulatory practice, the exchange has written to the company to seek information about any developments that could explain the unusual trading activity. The company is yet to respond to the exchange's query. This is a precautionary measure by the NSE to ensure investors have relevant and timely information.
This is a routine exchange query and does not indicate any wrongdoing or negative event. Investors should await the company's response, which may provide clarity on the reason for the volume surge. No immediate action is required from shareholders.